BayCom (BCML) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
22 Jan, 2026Executive summary
Reported Q4 2025 net income of $6.9 million ($0.63 per diluted share), up from $5.0 million in Q3 2025 and $6.1 million in Q4 2024.
Full-year 2025 net income rose 1.3% year-over-year to $23.9 million, driven by higher net interest income and lower noninterest expense.
Management highlighted growth in core lending, improved net interest income, and strengthened balance sheet through debt repayment and increased loan loss reserves.
Financial highlights
Net interest income for Q4 2025 was $25.0 million, up 6.8% from Q3 2025 and 6.1% from Q4 2024.
Annualized net interest margin rose to 4.03% from 3.68% in Q3 2025 and 3.80% in Q4 2024.
Return on average assets was 1.05% for Q4 2025, up from 0.75% in Q3 2025 and 0.94% in Q4 2024.
Noninterest income fell $1.4 million sequentially due to equity securities losses but rose $798,000 year-over-year.
Noninterest expense increased 1.4% sequentially and 1.2% year-over-year, mainly from higher salaries and data processing costs.
Provision for credit losses was $250,000 in Q4 2025, down from $3.0 million in Q3 2025 and up from a $403,000 reversal in Q4 2024.
Total assets were $2.6 billion at December 31, 2025, steady with Q3 2025 and down from $2.7 billion at year-end 2024.
Outlook and guidance
Management expects continued lending demand and stable credit quality in 2026.
Focus remains on disciplined loan growth, prudent credit risk management, and expense control.
Commitment to shareholder value through share repurchases and cash dividends.
Latest events from BayCom
- Director elections, say-on-pay, and auditor ratification headline a governance-focused agenda.BCML
Proxy Filing2 Dec 2025 - Annual meeting to vote on directors, executive pay, and auditor, with online proxy access.BCML
Proxy Filing2 Dec 2025 - Earnings declined on higher credit loss provisions, but capital and liquidity remain strong.BCML
Q3 20257 Nov 2025 - Q2 2024 net income fell 22% as margins compressed, but capital and deposits remained strong.BCML
Q2 202414 Oct 2025 - Earnings and net interest margin improved, with robust capital and higher nonperforming loans.BCML
Q2 202511 Aug 2025 - Q3 net loss widened to $16.8M; $182.2M cash on hand supports clinical pipeline into 2027.BCML
Q3 202413 Jun 2025 - Q1 2025 net income was $5.7M, with margin gains and robust capital ratios despite higher provisions.BCML
Q1 20256 Jun 2025 - Q4 2024 saw stable earnings, margin improvement, and strong credit quality at BayCom Corp.BCML
Q4 20245 Jun 2025